New and Generic Drug Approvals
November 13, 2014
| Drug Name | Active Ingredient | Dosage Form/Route | Sponsor | Submission Type |
|---|---|---|---|---|
| Actemra | tocilizumab | Injectable; Injection | Genentech | Labeling Revision |
| Advair Diskus 100/50 | fluticasone propionate; salmeterol xinafoate | Powder;Inhalation | Glaxo Grp Ltd | Labeling Revision |
| Advair Diskus 250/50 | fluticasone propionate; salmeterol xinafoate | Powder;Inhalation | Glaxo Grp Ltd | Labeling Revision |
| Advair Diskus 500/50 | fluticasone propionate; salmeterol xinafoate | Powder;Inhalation | Glaxo Grp Ltd | Labeling Revision |
| Advair Hfa | fluticasone propionate; salmeterol xinafoate | Aerosol, Metered;Inhalation | Glaxo Grp Ltd | Labeling Revision |
| Flovent Diskus 100 | fluticasone propionate | Powder;Inhalation | Glaxo Grp Ltd | Labeling Revision |
| Flovent Diskus 250 | fluticasone propionate | Powder;Inhalation | Glaxo Grp Ltd | Labeling Revision |
| Flovent Diskus 50 | fluticasone propionate | Powder;Inhalation | Glaxo Grp Ltd | Labeling Revision |
| Mycobutin | rifabutin | Capsule;Oral | Pharmacia and Upjohn | Labeling Revision |
| Zolmitriptan | zolmitriptan | Tablet;Oral | Sun Pharma Global | Approval |
No comments:
Post a Comment